CHC Healthcare Group (TPE:4164)
25.70
-0.15 (-0.58%)
Aug 19, 2026, 1:30 PM CST
CHC Healthcare Group Market Cap
CHC Healthcare Group has a market cap or net worth of 5.01 billion as of August 18, 2026. Its market cap has decreased by -41.94% in one year.
Market Cap
5.01B
Enterprise Value
9.66B
Revenue
4.65B
Ranking
n/a
PE Ratio
22.22
Stock Price
25.70
ChartMarket Cap Chart
Since October 18, 2011, CHC Healthcare Group's market cap has decreased from 9.89B to 5.01B, a decrease of -49.32%. That is a compound annual growth rate of -4.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 5.01B | -33.33% |
| Dec 31, 2025 | 7.52B | 7.82% |
| Dec 31, 2024 | 6.97B | -31.26% |
| Dec 29, 2023 | 10.15B | 44.21% |
| Dec 30, 2022 | 7.04B | 14.81% |
| Dec 30, 2021 | 6.13B | 3.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 584.35B |
| Caliway Biopharmaceuticals | 159.43B |
| Lin BioScience | 78.44B |
| Pell Bio-Med Technology | 68.36B |
| Formosa Optical Technology | 5.36B |
| Steminent Biotherapeutics | 5.32B |
| AnnJi Pharmaceutical | 5.17B |
| Cenra | 5.08B |